
Transcriptomic analysis reveals molecular alterations and candidate transcriptomic features associated with dapagliflozin treatment in patients with type 2 diabetes mellitus
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9JeHJfbmxFdzNLa3FwWm12cENucFlUTlFrUWtYdTJfTWg5YUI2bW0ycU1JTFZ2VWVMWnNjeHhBdjF1cVkyVXQ5RVMwXzdXLTNBcnVGbml5SGR1S1Z1d0lF?oc=5" target="_blank">Transcriptomic analysis reveals molecular alterations and candidate transcriptomic features associated with dapagliflozin treatment in patients with type 2 diabetes mellitus</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
